Start › Rak jajnika › Missouri › St. Louis
Badania kliniczne dla Rak jajnika w mieście St. Louis, MO
38 badań dla Rak jajnika szuka uczestników w ośrodkach w mieście St. Louis i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekrutacjaZapraszamy zdrowych ochotników
- Washington University School of Medicine, St Louis
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
RekrutacjaFaza 3
- Washington University School of Medicine in St. Louis, St Louis
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
RekrutacjaFaza 2/3
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- i 2 więcej
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekrutacjaFaza 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- i 6 więcej
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1
- Washington University Medicine, St Louis
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekrutacjaFaza 1
- Washington University School of Medicine in St. Louis, St Louis
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekrutacjaFaza 2
- Washington University, School of Medicine, St Louis
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
Rekrutacja
- WU St Louis, St Louis
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
RekrutacjaFaza 1/2
- Washington University, St Louis
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RekrutacjaFaza 2
- Mercy David C. Pratt Cancer Center /ID# 275655, St Louis
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekrutacjaBadanie obserwacyjne
- Washington University, St Louis
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekrutacjaFaza 1
- Washington University School of Medicine in St. Louis, St Louis
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RekrutacjaFaza 1/2
- Washington Univ. School of Medicine, St Louis
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RekrutacjaFaza 3
- Mercy Hospital St. Louis - David C. Pratt Cancer Center, St Louis
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RekrutacjaFaza 2
- Washington University, St Louis
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RekrutacjaFaza 1/2
- Research Site, St Louis
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
RekrutacjaFaza 3
- Washington University School of Medicine ( Site 0052), St Louis
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
RekrutacjaFaza 3
- Washington University School of Medicine, St Louis
- Mercy Hospital St. Louis, St Louis
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekrutacjaFaza 1/2
- Washington University School of Medicine, St Louis
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RekrutacjaFaza 1
- Washington University, Siteman Cancer Center, St Louis
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RekrutacjaFaza 1
- Normunity Investigational Site, St Louis
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Rekrutacja
- Washington University School of Medicine, St Louis
- Missouri Baptist Medical Center, St Louis
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekrutacjaFaza 3
- Mercy Infusion Center - Chippewa, St Louis
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- i 5 więcej
IDOV-Immune for Advanced Solid Tumors
RekrutacjaFaza 1
- Washington University School of Medicine, St Louis
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1/2
- Washington University, St Louis
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
RekrutacjaFaza 2/3
- Washington University School of Medicine Obstetrics and Gynecology, St Louis
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1
- Investigative Site #110, St Louis
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RekrutacjaFaza 2
- 521, St Louis
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekrutacjaFaza 1/2
- Washington University, St Louis
Lead-212 PSV359 Therapy for Patients With Solid Tumors
RekrutacjaFaza 1/2
- Saint Louis University, St Louis
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RekrutacjaFaza 1/2
- Washington University, St Louis
Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
RekrutacjaFaza 1
- Washington University School of Medicine in St. Louis, St Louis
JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation
RekrutacjaFaza 1/2
- Research site, St Louis
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
RekrutacjaFaza 3
- Washington University School of Medicine, St Louis
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
RekrutacjaFaza 1
- Site 0111, St Louis
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
Rekrutacja
- Washington University Medical Center, St Louis
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
RekrutacjaFaza 2
- Washington University, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekrutacjaBadanie obserwacyjne
- Massive Bio SYNERGY-AI site, St Louis
Badania dla Rak jajnika w innych miastach
- Houston, TX89 badań
- New York City, NY69 badań
- Boston, MA61 badań
- Los Angeles, CA50 badań
- Nashville, TN49 badań
- Arlington, VA46 badań
- Philadelphia, PA44 badań
- Columbus, OH39 badań
- Chicago, IL36 badań
- San Antonio, TX31 badań
- Cleveland, OH30 badań
- Pittsburgh, PA30 badań
Inne badania w mieście St. Louis
- Niedrobnokomórkowy rak płuca73 badań
- Rak piersi64 badań
- Nowotwór przerzutowy54 badań
- Rak jelita grubego i odbytnicy50 badań
- Nowotwory (wszystkie typy)46 badań
- Rak prostaty46 badań
- Rak płuc39 badań
- Rak trzustki33 badań
- Rak endometrium29 badań
- Rak płaskonabłonkowy głowy i szyi28 badań
- Niewydolność serca26 badań
- Otyłość25 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.